116 related articles for article (PubMed ID: 38295104)
1. The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis.
Li L; Li C; Miao F; Chen W; Kong X; Ye R; Feng R
Neoplasma; 2024 Feb; 71(1):48-59. PubMed ID: 38295104
[TBL] [Abstract][Full Text] [Related]
2. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer].
Yuan YQ; Zhang YX; Liu ZH; Qin CP; Sheng ZZ; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):571-6. PubMed ID: 26284387
[TBL] [Abstract][Full Text] [Related]
4. [CMTM5 inhibits the tumor cell behavior of prostate cancer by downregulation of HER2].
Xu T; Li J; Xiao YB; Liu ZH; Li Q; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):386-90. PubMed ID: 20721248
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
Guan L; Ji D; Liang N; Li S; Sun B
J Cell Mol Med; 2018 Jul; 22(7):3434-3441. PubMed ID: 29691981
[TBL] [Abstract][Full Text] [Related]
6. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X
Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568
[TBL] [Abstract][Full Text] [Related]
7. CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells.
Yuan Y; Sheng Z; Liu Z; Zhang X; Xiao Y; Xie J; Zhang Y; Xu T
J Cancer; 2020; 11(13):3762-3770. PubMed ID: 32328181
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiologic mechanism of CMTM5 low expression in multiple myeloma progression].
Ma Y; Shi JF; Qiu HY; Yuan J; Zhang Y; Zhou P; Xu JJ; Han QZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):58-62. PubMed ID: 30704230
[No Abstract] [Full Text] [Related]
9. Lower-Molecular-Weight Chitosan-Treated Polyethyleneimine: a Practical Strategy For Gene Delivery to Mesenchymal Stem Cells.
Liu M; Zhang L; Zhao Q; Jiang X; Wu L; Hu Y
Cell Physiol Biochem; 2018; 50(4):1255-1269. PubMed ID: 30355922
[TBL] [Abstract][Full Text] [Related]
10. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
[TBL] [Abstract][Full Text] [Related]
11. Polycations-functionalized water-soluble gold nanoclusters: a potential platform for simultaneous enhanced gene delivery and cell imaging.
Tao Y; Li Z; Ju E; Ren J; Qu X
Nanoscale; 2013 Jul; 5(13):6154-60. PubMed ID: 23727891
[TBL] [Abstract][Full Text] [Related]
12. Inducing Tumor Cell Apoptosis: Mediated Survivin miRNA by Ultrasound and Cationic Lipid Contrast Agent.
Yang F; Chun LF; Chen ZY
Curr Mol Med; 2021; 21(9):795-805. PubMed ID: 32912126
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of CMTM5 on xenografted human prostatic cancer in nude mice].
Xiao YB; Xie J; Zhang GX; Li J; Hao YC; Zhang XW; Liu ZH; Xu T; Wang XF
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):195-9. PubMed ID: 22474980
[TBL] [Abstract][Full Text] [Related]
15. Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances.
Chen Z; Cui N; Zhao JS; Wu JF; Ma F; Li C; Liu XY
Eur J Histochem; 2021 Jan; 65(1):. PubMed ID: 33478201
[TBL] [Abstract][Full Text] [Related]
16. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ
Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma.
Liang C; Sun W; He H; Zhang B; Ling C; Wang B; Huang T; Hou B; Guo Y
Int J Nanomedicine; 2018; 13():209-220. PubMed ID: 29343959
[TBL] [Abstract][Full Text] [Related]
18. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
Zhang C; Yuan W; Wu Y; Wan X; Gong Y
Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
[TBL] [Abstract][Full Text] [Related]
20. [Physicochemical characters and gene delivery function of polyethylenimine modified with peptide CP9 containing RGD sequence].
Li D; Wang QQ; Tang GP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 35(6):615-21. PubMed ID: 17177333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
